Annie reflects on the challenges faced in biotech during the early 2000s and how those difficulties led her to pivot towards cloud software and fintech. She emphasizes the importance of intellectual curiosity and the opportunities that arise from market resets, particularly during the 2008 financial crisis, which allowed for strategic investments at favorable valuations in both fintech and healthcare.
